semaglutide 15mg GLP-1 S Zydus Rolls Out Semaglutide Injection
Description
Risk vs
Your doctor or dietician will advise a reduced caloric intake combined with increased physical activity for best results
GLP-1 receptor agonists cause nausea by delaying gastric emptying, with rates varying from 8% to 44% depending on the specific medication and dose
Results showed a critically low glucose level at 33mg/dL
This is because the medication helps control appetite, and once it is discontinued, hunger may increase again
